These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 13121859)

  • 1. [Carcinogenic action of nitrogen mustard; experimental research].
    NARPOZZI A
    Riv Anat Patol Oncol; 1953 May; 6(8):1155-70. PubMed ID: 13121859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiments on the mechanism of action of carcinogenic hydrocarbons. V. Experimental studies on the problem of action of carcinogenic hydrocarbons in the sense of a general tumor disposition].
    GRAFFI A; REISSIG G
    Arch Geschwulstforsch; 1957; 10(2):146-55. PubMed ID: 13445091
    [No Abstract]   [Full Text] [Related]  

  • 3. [The presumed carcinogenic action of nitrogen mustard].
    NARPOZZI A
    Boll Soc Ital Biol Sper; 1954; 30(8-11):1168-70. PubMed ID: 14363469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Supposed mutagenic action of carcinogenic substances].
    POLETTINI B; NARPOZZI A
    Boll Soc Ital Biol Sper; 1953 May; 29(5):1064-6. PubMed ID: 13106122
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.
    Leung HW; Kamendulis LM; Stott WT
    Regul Toxicol Pharmacol; 2005 Dec; 43(3):260-71. PubMed ID: 16188361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of exposure to carcinogens beginning during developmental life.
    Soffritti M; Belpoggi F; Esposti DD; Falcioni L; Bua L
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):118-24. PubMed ID: 18226064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern criteria to determine the etiology of human carcinogens.
    Mossman BT; Klein G; Zur Hausen H
    Semin Cancer Biol; 2004 Dec; 14(6):449-52. PubMed ID: 15489138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARCINOGENIC PROPERTIES OF NUTS FROM CYCAS CIRCINALIS L. INDIGENOUS TO GUAM.
    LAQUEUR GL; MICKELSEN O; WHITING MG; KURLAND LT
    J Natl Cancer Inst; 1963 Oct; 31():919-51. PubMed ID: 14069834
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis.
    Kawata K; Shimazaki R; Okabe S
    Environ Mol Mutagen; 2009 Jan; 50(1):46-59. PubMed ID: 19031421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the mechanism of action of carcinogenic hydrocarbons. IV. Studies on the dependence of the initial effect of carcinogenic hydrocarbons on the genetic constitution of test animals].
    GRAFFI A; REISSIG G
    Arch Geschwulstforsch; 1956; 10(1):1-15. PubMed ID: 13395391
    [No Abstract]   [Full Text] [Related]  

  • 12. The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible?
    Mueck AO; Seeger H
    Gynecol Endocrinol; 2008 Mar; 24(3):129-32. PubMed ID: 18335326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of action of nitrogen mustard in experimental & clinical rheumatology].
    VYKYDAL M; KLABUSAY L
    Arzneimittelforschung; 1957 Aug; 7(8):516-20. PubMed ID: 13459814
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the protective action of beta-mercaptoethylamine in experimental poisonings by nitrogen mustard].
    PAPPALARDO M
    Riv Patol Clin; 1960 Dec; 15():976-82. PubMed ID: 13732681
    [No Abstract]   [Full Text] [Related]  

  • 15. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IARC monographs program on carcinogenicity of combined hormonal contraceptives and menopausal therapy.
    Schneider HP; Mueck AO; Kuhl H
    Climacteric; 2005 Dec; 8(4):311-6. PubMed ID: 16390765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
    Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
    Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rubber industry and exposure to carcinogenic chemical agents: an Italian Multicentric Study in Lombardy].
    Cirla PE; Tieghi S; Trinco R; Galli L; Filipponi A; Pavesi D; Martinotti I; Foà V; Cirla AM; Mossini E
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):317-9. PubMed ID: 18409704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of chemical and physical factors in cancer development].
    Gundy S
    Magy Onkol; 2006; 50(1):5-18. PubMed ID: 16617378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency.
    Venkatapathy R; Wang CY; Bruce RM; Moudgal C
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):209-21. PubMed ID: 18977375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.